These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 26433051

  • 21. Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses.
    Iba Y, Fujii Y, Ohshima N, Sumida T, Kubota-Koketsu R, Ikeda M, Wakiyama M, Shirouzu M, Okada J, Okuno Y, Kurosawa Y, Yokoyama S.
    J Virol; 2014 Jul; 88(13):7130-44. PubMed ID: 24719430
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Human COBRA 2 vaccine contains two major epitopes that are responsible for eliciting neutralizing antibody responses against heterologous clades of viruses.
    Nuñez IA, Ross TM.
    Vaccine; 2020 Jan 22; 38(4):830-839. PubMed ID: 31733946
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Re-emergence of H3N2 strains carrying potential neutralizing mutations at the N-linked glycosylation site at the hemagglutinin head, post the 2009 H1N1 pandemic.
    Ushirogawa H, Naito T, Tokunaga H, Tanaka T, Nakano T, Terada K, Ohuchi M, Saito M.
    BMC Infect Dis; 2016 Aug 08; 16():380. PubMed ID: 27503338
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H, Liu XF, Zhang X, Chen S, Sun L, Lu J.
    Vaccine; 2007 Oct 16; 25(42):7379-84. PubMed ID: 17870216
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Influenza Virus Hemagglutinins H2, H5, H6, and H11 Are Not Targets of Pulmonary Surfactant Protein D: N-Glycan Subtypes in Host-Pathogen Interactions.
    Parsons LM, An Y, Qi L, White MR, van der Woude R, Hartshorn KL, Taubenberger JK, de Vries RP, Cipollo JF.
    J Virol; 2020 Feb 14; 94(5):. PubMed ID: 31826991
    [Abstract] [Full Text] [Related]

  • 38. Hemagglutinin glycosylation modulates the pathogenicity and antigenicity of the H5N1 avian influenza virus.
    Zhang X, Chen S, Jiang Y, Huang K, Huang J, Yang D, Zhu J, Zhu Y, Shi S, Peng D, Liu X.
    Vet Microbiol; 2015 Feb 25; 175(2-4):244-56. PubMed ID: 25544041
    [Abstract] [Full Text] [Related]

  • 39. Development of broadly reactive H5N1 vaccine against different Egyptian H5N1 viruses.
    Ibrahim M, Sultan HA, Razik AG, Kang KI, Arafa AS, Shehata AA, Saif YM, Lee CW.
    Vaccine; 2015 May 28; 33(23):2670-7. PubMed ID: 25910922
    [Abstract] [Full Text] [Related]

  • 40. A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection.
    Du L, Zhao G, Sun S, Zhang X, Zhou X, Guo Y, Li Y, Zhou Y, Jiang S.
    PLoS One; 2013 May 28; 8(1):e53568. PubMed ID: 23320093
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.